Means–Lerman scratch

From WikiMD's WELLNESSPEDIA

Means–Lerman Scratch

TheMeans–Lerman scratch is a rare cardiac auscultatory phenomenon associated with hyperdynamic circulation, particularly in the context of thyrotoxicosis. It is characterized by a scratching or rasping sound heard during auscultation of the heart, typically over the precordium.

History[edit]

The Means–Lerman scratch was first described by J. H. Means and J. Lerman in the early 20th century. Their observations were based on patients with Graves' disease, a common cause of thyrotoxicosis, who exhibited this unique auscultatory finding.

Pathophysiology[edit]

The exact mechanism of the Means–Lerman scratch is not fully understood, but it is believed to be related to the increased cardiac output and hyperdynamic state seen in conditions like thyrotoxicosis. The sound is thought to be produced by the rubbing of the pericardial surfaces or the vibration of cardiac structures due to the increased force of cardiac contractions.

Clinical Significance[edit]

The presence of a Means–Lerman scratch can be an important clinical clue in diagnosing hyperthyroid conditions. It is, however, a rare finding and not commonly encountered in routine clinical practice. When present, it should prompt further investigation into the patient's thyroid function and overall cardiovascular status.

Diagnosis[edit]

Diagnosis of the Means–Lerman scratch is primarily clinical, based on auscultation. It is important to differentiate it from other cardiac sounds such as pericardial friction rubs or murmurs. A thorough clinical examination and correlation with other signs and symptoms of thyrotoxicosis are essential.

Management[edit]

Management of the Means–Lerman scratch involves addressing the underlying cause of the hyperdynamic circulation. In cases of thyrotoxicosis, treatment may include antithyroid medications, radioactive iodine therapy, or surgical intervention. Once the underlying condition is controlled, the auscultatory finding typically resolves.

Also see[edit]


Cardiovascular disease A-Z

Most common cardiac diseases

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

A[edit]

B[edit]

C[edit]

D[edit]

E[edit]

H[edit]

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

I[edit]

K[edit]

L[edit]

M[edit]

N[edit]

O[edit]

P[edit]

R[edit]

S[edit]

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

T[edit]

V[edit]

W[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.